What was known before {#section19-2054358117722782}
=====================

In 2011, the Kidney Failure Risk Equation (KFRE) was developed and has subsequently been shown to be highly accurate in predicting the progression of chronic kidney disease (CKD) to kidney failure.

What this adds {#section20-2054358117722782}
==============

A threshold risk of 3% over 5 years for kidney failure, as determined by the KFRE, can be integrated into a triage process, and reduce wait times for nephrology care.

Background {#section21-2054358117722782}
==========

Chronic kidney disease (CKD) is a major public health problem that is associated with increased morbidity and mortality.^[@bibr1-2054358117722782],[@bibr2-2054358117722782]^ CKD is often a "silent" disease, whereby disease-related symptoms typically present in later stages.^[@bibr2-2054358117722782],[@bibr3-2054358117722782]^ Identifying patients with CKD early in their disease trajectory and implementing specific treatments may prevent adverse complications such as progression to end-stage kidney disease (ESKD), acute kidney injury, and cardiovascular disease.^[@bibr2-2054358117722782],[@bibr4-2054358117722782]^ As such, most international clinical practice guidelines recommend using estimated glomerular filtration rate (eGFR) and albuminuria for the identification, monitoring, and classification of CKD.^[@bibr5-2054358117722782],[@bibr6-2054358117722782]^

Primary care providers usually test for kidney disease by estimating GFR using serum creatinine and by testing for protein in the urine. Automated eGFR reporting in the general population has led to a substantial increase in the recognition of CKD (eGFR \<60 mL/min/1.73 m^2^) in older populations, generating an increase in referrals to specialized nephrology care teams.^[@bibr7-2054358117722782]^ A substantial proportion of this newly recognized CKD population is considered at low risk of progression to kidney failure (reference companion paper). In many of these patients, nephrology referral may not necessarily lead to improvement of long-term outcomes.^[@bibr8-2054358117722782],[@bibr9-2054358117722782]^ Concurrently, the increase in referrals in resource-limited settings has led to significant wait times, higher costs, and potentially less access to care for patients at higher risk of kidney failure.^[@bibr8-2054358117722782],[@bibr10-2054358117722782][@bibr11-2054358117722782]-[@bibr12-2054358117722782]^ Our own experience with automatic eGFR reporting suggested a large increase in low-risk referrals who did not meet prespecified criteria for nephrology care.^[@bibr13-2054358117722782]^

In 2011, the Kidney Failure Risk Equation (KFRE) was developed and has subsequently been shown to be highly accurate in predicting the progression of CKD to kidney failure.^[@bibr14-2054358117722782]^ Since that time, the KFRE has been extensively validated in multiple diverse CKD populations worldwide.^[@bibr15-2054358117722782][@bibr16-2054358117722782][@bibr17-2054358117722782][@bibr18-2054358117722782]-[@bibr19-2054358117722782]^ In 2012, as response to increased nephrology wait times, we arrived at 3% risk threshold over 5 years as a criterion for nephrology referrals through physician consensus. This threshold represents the risk for a 70-year-old male with an eGFR of 45 mL/min/1.73 m^2^ and 15 mg/mmol of albuminuria.

Subsequently, we validated the KFRE in our province and demonstrated that this risk threshold of 3% over 5 years is 97% sensitive and 62% specific for predicting progression to kidney failure, with a negative predictive value of 99% (reference companion paper). Here, we describe the results from our quality improvement initiative, using the KFRE and these thresholds as part of a triage tool for referrals, in an effort to improve timely access to specialist care through improved wait times.

Methods {#section22-2054358117722782}
=======

Study Population {#section23-2054358117722782}
----------------

Manitoba (population 1.27 million) is a province situated in central Canada. It has the second highest incidence and prevalence of ESKD in Canada.^[@bibr20-2054358117722782]^ Winnipeg, the provincial capital city, is where more than half of the provincial population is concentrated. The remainder of the population is dispersed over a large area of 649 950 km^2^.^[@bibr21-2054358117722782]^ Manitoba is culturally diverse with almost 10% of the population being a member of a visible minority, and 14% of Aboriginal origin.^[@bibr22-2054358117722782],[@bibr23-2054358117722782]^

Our initiative was exempt from institutional review board approval as it was deemed a quality improvement project, with less than minimal risk to patients and with all patients de-identified.

Manitoba Renal Program {#section24-2054358117722782}
----------------------

The Manitoba Renal Program (MRP) is responsible for providing all CKD care for patients referred to nephrology, as well as the ESKD services in the province. In Winnipeg, there are 3 renal centers, which together care for and assess the majority of new nephrology referrals (CKD and dialysis) within the MRP. One other center in Brandon, Manitoba, a city of 46 000 people,^[@bibr24-2054358117722782]^ sees a minority of total provincial referrals and primarily sees referrals from its catchment area only. Those consultations were not included in this study. The MRP provides referral pathways and standard referral forms for clinicians, which can be found at [www.kidneyhealth.ca](http://www.kidneyhealth.ca).

eGFR reporting in Manitoba began in October of 2010, and KFRE triage was started in January 1, 2012. We collected referral counts, wait times, and demographic data on all Winnipeg-directed referrals sent to 2 of the 3 renal centers in the MRP between January 1, 2011, and December 31, 2011, in the pretriage period, and January 1, 2013, and December 31, 2013, in the posttriage period. Wait times for each patient were defined as the time between referral and actual visit to a nephrologist, measured in days. A 12-month period immediately following implementation of triage was observed as a transition period to the new triage system and was excluded from the final analysis.

Referrals in the pretriage period included data on patient name, provider name, and date of referral and appointment. In contrast, all referrals made in the posttriage period had data collected for demographics, comorbidities, serum biochemistry markers (GFR, creatinine, hemoglobin, calcium, phosphate, and albumin), and urine albumin:creatinine ratio (ACR).

Kidney Failure Risk Equation {#section25-2054358117722782}
----------------------------

The 4-variable KFRE was calculated for each referral using the variables age, sex, eGFR, and quantified urinary proteinuria (ACR; or protein:creatinine or 24-hour urine protein normalized to ACR). These values were entered by our physician assistant into the online calculator at uniform resource locator <http://www.qxmd.com/calculate-online/nephrology/kidney-failure-risk-equation>. The generated score as a 5-year risk of kidney failure was recorded on the initial referral for review by the nephrologist. A patient with a score ≥3% was labeled as high risk for progression to kidney failure, and a score \<3% was classified as low risk.

If all values were not included in the original referral, a search was done on our provincial database (eCHART) and a request was made to the referring physician for more complete information. No consults were triaged unless all 4 variables were available, or another indication for nephrology referral was provided on the referral letter/form.

Triage Systems {#section26-2054358117722782}
--------------

Referrals in the pretriage period were sent to a specific site for either a specific physician or into a general pool to distribute among physicians at the site. Once referrals were received, they were triaged as urgent, nonurgent, or "do not book" by an individual rotating nephrologist. There were no set criteria or risk-based calculations applied in this period, and acuity was solely at the discretion of the nephrologist. We define referrals are consultations that are booked for a visit with a nephrologist.

In the posttriage period, each referral was considered in the context of the triage scheme based on the KFRE, or if another indication was listed for specialist consultation ([Figure 1](#fig1-2054358117722782){ref-type="fig"}). Referrals were deemed as appropriate if any of the significant criteria for referral were met, or if the 5-year risk score was greater than 3% for ESKD. If none of these criterions were present, patients were noted to have a low predicted risk and a letter was sent back to the referring provider explaining the relatively low risk for progression to kidney failure, and a brief outline of further management suggestions for the patient. In addition, referring clinicians were invited to contact the nephrologist for any questions, concerns, or if the clinician felt a consultation with a nephrologist was still warranted. These patients would then be booked without further discussion. Referrals were seen urgently if the patient had an eGFR of less than 15, whereas other significant indications were triaged primarily dependent on indication and clinical context.

![Process for triage of referrals.\
*Note.* eGFR = estimated glomerular filtration rate; ACR = albumin:creatinine ratio; PCR = protein:Creatinine Ratio; GP = general Practitioner; GN = glomerulonephritis.](10.1177_2054358117722782-fig1){#fig1-2054358117722782}

Data Analysis {#section27-2054358117722782}
-------------

The median wait time and number of consults were compared between the pretriage and posttriage periods using a general linear model. Each model contained a variable for reporting month, an indicator variable representing the posttriage period, and an interaction term between the reporting month and posttriage indicator. The change in slope following triage was represented by the coefficient of the interaction term between reporting month and the triage indicator variable. Demographic comparisons were made between the low- and high-risk groups in the posttriage period. Continuous variables are expressed as median and interquartile range (IQR) and compared between both groups using the Mann-Whitney *U* test. Categorical variables are expressed as frequencies and percentages and compared between both groups using a chi-square test. All statistical analysis was performed using SAS version 9.2 (Cary, North Carolina) for Microsoft Windows. Visual representations of these models were developed using Microsoft Excel 2010 (Seattle, Washington).

Results {#section28-2054358117722782}
=======

Patient Characteristics {#section29-2054358117722782}
-----------------------

Baseline characteristics of the posttriage referral groups are shown in [Table 1](#table1-2054358117722782){ref-type="table"}. The median age of the patients was 68, with an equal number of males and females. The median eGFR at referral was 39 mL/min/1.73 m^2^ (IQR: 27.4-55.2), and the median urine ACR was 9.2 mg/mmol (IQR: 1.6-65.5). A low eGFR was the primary reason for referral by the referring clinician for 66% of the patients, followed by proteinuria in 20.4% of referrals. Other indications including suspected glomerulonephritis and electrolyte disorders made up less than 15% of all referrals.

###### 

Posttriage Period Patient Demographics.

![](10.1177_2054358117722782-table1)

                                                     Total                Low-risk strata not booked   Low-risk strata booked   High-risk strata      *P* value
  -------------------------------------------------- -------------------- ---------------------------- ------------------------ --------------------- -----------
  Age                                                67.7 (56.3-77.9)     67.7 (56.3-74.6)             59.1 (43.8-68.7)         72.2 (61.8-80.8)      \<.0001
  Gender                                                                                                                                              .4395
  Male                                               50.3%                46.8%                        52.4%                    51.2%                 
  Female                                             49.7%                53.0%                        47.6%                    48.8%                 
  Indication                                                                                                                                          \<.0001
   0 (not indicated)                                 2.0%                 4.0%                         0.7%                     1.3%                  
   1 (decreased eGFR/increased creatinine)           65.8%                62.4%                        31.4%                    79.5%                 
   2 (hematuria with eGFR \<60 mL/min/1.73 m^2^)     0.7%                 0.8%                         0.7%                     0.7%                  
   3 (hematuria with eGFR \>60 mL/min/1.73 m^2^)     1.3%                 2.8%                         2.6%                     0.0%                  
   4 (proteinuria with eGFR \<60 mL/min/1.73 m^2^)   10.8%                4.0%                         4.6%                     16.6%                 
   5 (proteinuria with eGFR \>60 mL/min/1.73 m^2^)   9.6%                 14.8%                        27.5%                    0.2%                  
   6 (suspected glomerulonephritis)                  2.9%                 0.0%                         13.7%                    0.9%                  
   7 (others)                                        7.0%                 11.2%                        19.0%                    0.9%                  
  Triage                                                                                                                                              \<.0001
   Urgent                                            35.2%                0.0%                         34.7%                    55.0%                 
   Nonurgent                                         31.0%                0.0%                         65.3%                    37.8%                 
   Not booked                                        33.8%                100.0%                       0.0%                     7.3%                  
  Urinalysis available                               63.4%                65.8%                        72.9%                    59.6%                 
  SCr, µmol/L                                        135.0 (98.0-182.0)   108.0 (84.0-124.0)           92.0 (68.0-123.0)        176.0 (149.6-224.0)   \<.0001
  Calcium, mmol/L                                    2.33 (2.27-2.42)     2.33 (2.29-2.44)             2.32 (2.22-2.42)         2.32 (2.26-2.40)      .3611
  Phosphate, mmol/L                                  1.17 (1.06-1.32)     1.10 (0.99-1.24)             1.14 (1.05-1.29)         1.26 (1.14-1.46)      \<.0001
  Albumin, g/L                                       38.0 (35.0-42.0)     40 (37.0-44.0)               38.0 (33.0-42.0)         36.0 (33.0-40.0)      \<.0001
  HCO~3~ (TCO~2~), mmol/L                            26.0 (23.0-28.0)     28.0 (26.0-30.0)             26.0 (24.0-28.0)         24.0 (21.0-27.0)      \<.0001
  Urine ACR, mg/mmol                                 9.2 (1.6-65.5)       1.5 (0.4-12.8)               17.6 (1.0-89.4)          22.6 (5.8-165.1)      \<.0001
  eGFR, mL/min/1.73 m^2^                             38.6 (27.4-55.2)     52.4 (43.7-60.0)             60.0 (47.3-60.0)         28.8 (21.8-36.4)      \<.0001

*Note.* eGFR = estimated glomerular filtration rate; SCr = serum creatinine; ACR = albumin:creatinine ratio.

Effect of Triage on Referrals and Wait Times {#section30-2054358117722782}
--------------------------------------------

In the posttriage period, 35% of referrals were booked as urgent, 31% as nonurgent, and 34% of referrals were not booked ([Table 1](#table1-2054358117722782){ref-type="table"}). Low-risk patients were younger, had a higher eGFR (57 vs 29 mL/min/1.73 m^2^, *P* \< .001), and lower urinary albumin excretion (3.4 vs 22.6 mg/mmol, *P* \< .01) compared with the high-risk patients.

In the low-risk group, 64% of the low-risk patients were not booked. The remaining 36% met other indications for nephrology consultation, with 13% booked as urgent and 23% as nonurgent. Of high-risk referrals, 55% were booked as urgent. In all, 7% of the high-risk consultations were not booked as they were related to community-acquired acute kidney injury that had already resolved by the time of referral.

In 2011, the monthly number of referrals ranged from 44 to 76, with a median number of monthly referrals being 68/month. In the posttriage period, the monthly referrals ranged from 61 to 147, with a median number of monthly referrals of 94/month. This was a monthly referral increase of 45%. The median number of high-risk referrals in the posttriage period was 49/month ([Figure 2](#fig2-2054358117722782){ref-type="fig"}).

![Number of referrals in pretriage and posttriage periods.](10.1177_2054358117722782-fig2){#fig2-2054358117722782}

The median wait times for nephrology care in the pretriage period ranged from 126 to 355 days, with a median wait time of 230 days for the entire year. In the posttriage period, the monthly median wait time range decreased to 48 to 69 days, with a median wait time of 58 days ([Figure 3](#fig3-2054358117722782){ref-type="fig"}).

![Median wait time in pretriage and posttriage periods.\
*Note.* Intervention resulted in statistically significant change in wait time (*P* \< .001) and change in wait time trend (slope) post intervention (*P* = .029).](10.1177_2054358117722782-fig3){#fig3-2054358117722782}

Discussion {#section31-2054358117722782}
==========

Our risk-based triage scheme led to an overall improvement in wait times. In turn, this expedited access to care for the patients at highest risk of progression to ESKD. Reduced consult volumes allow interprofessional teams and nephrologist time and resources to be concentrated on patients at highest risk of progression to ESKD. Interventions to slow the progression of CKD are demonstrated as more cost-effective in this cohort of patients.^[@bibr25-2054358117722782],[@bibr26-2054358117722782]^ Our proposed triage scheme, if implemented in other jurisdictions, could provide better value for money at a system-wide level.

Many areas within the health care system have implemented triage systems to access services with limited resources (eg, specialized operative skills), higher cost (eg, certain medications for orphan diseases) or variable, and unpredictable demand (eg, emergency departments). In many nephrology practices, triage schemes have typically relied on ad hoc criteria and are rarely evaluated in a prospective manner.^[@bibr27-2054358117722782],[@bibr28-2054358117722782]^ Our triage system acknowledges that not every patient with CKD is at high risk of progression to ESKD, and may not require specialist- or interdisciplinary team--based care as a result. It also provides a standardized, validated metric on which to focus limited health care resources providing greater value for money. Other medical subspecialties have carried similar principles of risk-based triage to ensure high-risk patients are seen in a timely manner.^[@bibr6-2054358117722782],[@bibr17-2054358117722782],[@bibr29-2054358117722782],[@bibr30-2054358117722782]^

Our novel approach provides a standardized pathway to triaging low-risk patients and objectively allows higher risk referrals to be identified. When referrals are not felt to be indicated, we provide individualized correspondences back to referring providers on suggested management and continued surveillance of patients, as well as when a referral to nephrology should be reinitiated. It is important to note that the KFRE is only a part of our triage process, and other indications and the broader clinical context are equally weighted when triaging referrals. As such, our approach has a built-in safety check to ensure that patients who have other indications to see a nephrologist despite a low 5-year risk of progression are still seen. For instance, a 30-year-old patient with hematuria and suspected glomerulonephritis has a low 5-year risk using the KFRE. However, this patient would be seen by our program on the account of their high lifetime risk, as would a low-risk patient with a significant metabolic or electrolyte abnormality.

Interventions in conjunction with the KFRE could aid further in CKD identification and management. In low-risk patients, multidisciplinary nephrology care is unlikely to change treatment or prognosis, as this population generally has a low prevalence of CKD-related complications.^[@bibr31-2054358117722782]^ There is limited evidence linking patients at low risk of progression managed by nephrology teams to improved health outcomes.^[@bibr32-2054358117722782]^ A previous study in England evaluated patients with CKD in their national primary care registry, and used National Institute for Health and Clinical Excellence (NICE) guidelines to prompt treatment for all patients and nephrology referral for only high-risk patients. They found that the majority of patients with CKD usually are being treated for 1 modifiable CKD risk factor and that most interventions could be delivered efficiently in a primary care setting. Only 6% of higher risk or more complex patients required nephrology intervention.^[@bibr33-2054358117722782]^ Educational programs on the importance of risk-based management, targeted at primary care physicians, can help these physicians better recognize and manage CKD.^[@bibr34-2054358117722782]^ Risk prediction for cardiovascular disease is already well integrated in primary care. Similarly, effective knowledge translation strategies can help to integrate risk-based management of CKD for most patients. The KFRE with its existing point-of-care smartphones and web platforms is effectively positioned for this purpose. Further integration of this tool into electronic medical records or automated lab reporting could further enhance efficient clinical decision making for appropriate nephrology referrals.

Using the KFRE as a triage tool has several clinical implications. First, where nephrology resources are constrained, we have demonstrated that risk-based triage is an effective health policy tool to improve wait times and access to care for the patients at highest risk of progression to end stage. Our previous study reported a median wait time of 150 days for urgent referrals in June 2011, which is almost 3 times the median wait time in the posttriage period. Through estimating ESKD risk, the allocation of resources can be focused on higher risk patients. Our example for referral triage only shows 1 potential use of the KFRE. Other thresholds at different stages of CKD could inform different decisions. For example, vascular access planning at 20% per year and multidisciplinary clinic enrollment at 5% per year could be potential cutoff points. While these are currently in clinical use, their utilization effecting patient outcomes remains to be studied. In settings without significant referral wait times, the KFRE could still be used to determine priority of referral, and intensity of follow-up.

Our study has several strengths, including using a validated risk prediction model that has been validated in multiple populations.^[@bibr15-2054358117722782][@bibr16-2054358117722782][@bibr17-2054358117722782][@bibr18-2054358117722782]-[@bibr19-2054358117722782]^ The KFRE uses common, widely available laboratory and demographic variables rendering this a low-cost implementation.^[@bibr14-2054358117722782],[@bibr19-2054358117722782]^ In addition, as our triage approach combined information on risk (KFRE) with additional "red flags" based on clinical judgment, it was able to capture those with other important indications for nephrology referral despite a low 5-year risk. Our study also has limitations. We do not have long-term follow-up on patients triaged as low-risk in this era. However, we have previously confirmed, in an earlier cohort of patients in Manitoba (reference companion manuscript), that patients identified as low risk according to the KFRE do indeed have very low observed rates of kidney failure over 5 years (\<1%). Our study may not be applicable to all nephrology teams, especially those operating under capacity without wait lists. We did not collect detailed information on all referrals in the pretriage period, so any differences in our pretriage and posttriage patient groups may be unaccounted for. However, our previous manuscript on wait times following eGFR implementation in 2011^[@bibr13-2054358117722782]^ used this same cohort and reported similar group characteristics. Also, we were not able to account for a potential Hawthorne effect on wait times, and other additional changes may have led to our improved wait times. This included additional capacity to see new referrals by 1 additional nephrologist being hired in September 2013, and a physician assistant--led clinic being started in September 2012. The physician assistant saw the same number of patients in both periods, and with the addition of a nephrologist lowered the average number of new referrals per nephrologist from 8.2 to 6.9 (16% decrease). Given that wait times decreased by 75%, we believe that the increased clinician capacity and a potential Hawthorne effect cannot fully explain the improved wait times. These certainly had an impact on our wait times; the risk-based triage process eliminated the need for one-third of all referrals to be seen.

Conclusions {#section32-2054358117722782}
===========

In conclusion, a threshold risk of 3% over 5 years for kidney failure, as determined by the KFRE, can be integrated into a triage process, and reduce wait times for nephrology care and help direct resources to those patients at highest risk of progression to ESKD. Studies examining the effect of risk-based care on other important clinical decisions in CKD are needed.
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